1. Home
  2. CCLD vs HUMA Comparison

CCLD vs HUMA Comparison

Compare CCLD & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareCloud Inc.

CCLD

CareCloud Inc.

HOLD

Current Price

$3.05

Market Cap

114.0M

Sector

Technology

ML Signal

HOLD

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$0.69

Market Cap

134.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCLD
HUMA
Founded
1999
2004
Country
United States
United States
Employees
3650
184
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
114.0M
134.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CCLD
HUMA
Price
$3.05
$0.69
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$6.19
AVG Volume (30 Days)
605.8K
5.8M
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$11.49
$444.16
Revenue Next Year
$7.95
$248.39
P/E Ratio
$32.04
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.56
$0.55
52 Week High
$4.01
$2.93

Technical Indicators

Market Signals
Indicator
CCLD
HUMA
Relative Strength Index (RSI) 46.86 43.71
Support Level $2.83 $0.55
Resistance Level $3.14 $1.27
Average True Range (ATR) 0.19 0.06
MACD -0.02 0.02
Stochastic Oscillator 45.67 53.04

Price Performance

Historical Comparison
CCLD
HUMA

About CCLD CareCloud Inc.

CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes. Its comprehensive suite includes Electronic Health Records (EHRs), Practice Management, Revenue Cycle Management (RCM), Medical Billing, Telehealth, and Patient Experience solutions. The group helps practices increase efficiency, improve patient care, and drive sustainable growth-all while ensuring HIPAA compliance and seamless integration. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: